Silence Therapeutics plc (OTCMKTS:SLNCF – Get Free Report)’s share price traded down 14.2% during mid-day trading on Monday . The stock traded as low as $4.00 and last traded at $5.25. 2,400 shares changed hands during trading, an increase of 30% from the average session volume of 1,853 shares. The stock had previously closed at $6.12.
Silence Therapeutics Stock Down 14.2 %
The stock’s 50 day simple moving average is $6.85 and its 200 day simple moving average is $7.01.
Silence Therapeutics Company Profile
Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development novel molecules incorporating short interfering ribonucleic acid (siRNA) to inhibit the expression of specific target genes in hematology, cardiovascular, and rare diseases. The company's mRNAi GalNAc Oligonucleotide Discovery platform consists of precision engineered product candidates designed to target specific disease-associated genes in the liver.
See Also
- Five stocks we like better than Silence Therapeutics
- ESG Stocks, What Investors Should Know
- Autodesk Stock: Analysts’ Top AI Pick You Shouldn’t Overlook
- Dividend Capture Strategy: What You Need to Know
- Hidden Opportunities in Li Auto’s Tough Quarter You Can’t Miss
- How to Use the MarketBeat Excel Dividend Calculator
- Don’t Overlook Campbell Soup: Here’s What Could Drive Its Stock
Receive News & Ratings for Silence Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Silence Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
